Nu Skin Enterprises Inc. (NYSE:NUS) updated its FY13 earnings guidance on Thursday. The company provided earnings per share guidance of $7.25-7.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.83, Analyst Ratings Network.com reports. The company issued revenue guidance of $3.9-4.0 billion, compared to the consensus revenue estimate of $3.20 billion.
A number of research firms have recently commented on NUS. Analysts at Ned Davis Research downgraded shares of Nu Skin Enterprises from a buy rating to a neutral rating in a research note to investors on Monday. On a related note, analysts at Zacks upgraded shares of Nu Skin Enterprises from a neutral rating to an outperform rating in a research note to investors on Thursday, October 31st. They now have a $120.20 price target on the stock. Finally, analysts at Wedbush raised their price target on shares of Nu Skin Enterprises from $103.00 to $130.00 in a research note to investors on Wednesday, October 23rd. They now have an outperform rating on the stock. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $117.17.
Shares of Nu Skin Enterprises Inc. (NYSE:NUS) opened at 114.74 on Thursday. Nu Skin Enterprises Inc. has a 52 week low of $32.36 and a 52 week high of $120.82. The stock has a 50-day moving average of $108.3 and a 200-day moving average of $83.98. The company has a market cap of $6.825 billion and a price-to-earnings ratio of 23.48.
Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Tuesday, October 22nd. The company reported $1.80 EPS for the quarter, beating the consensus estimate of $1.41 by $0.39. The company had revenue of $927.00 million for the quarter, compared to the consensus estimate of $806.19 million. During the same quarter last year, the company posted $0.87 earnings per share. Nu Skin Enterprises’s revenue was up 76.3% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises Inc. will post $5.90 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, December 4th. Stockholders of record on Friday, November 22nd will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend is Wednesday, November 20th.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 20,000 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $112.50, for a total value of $2,250,000.00. Following the completion of the transaction, the general counsel now directly owns 30,255 shares of the company’s stock, valued at approximately $3,403,688. The transaction was disclosed in a filing with the SEC, which is available at this link.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.